Familial Hypercholesterolemia in the Danish General Population: Prevalence, Coronary Artery Disease, and Cholesterol-Lowering Medication
The DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.
Abstract
Context: The diagnosis of familial hypercholesterolemia (FH) can be made using the Dutch Lipid Clinic Network criteria. This employs the personal and family history of premature coronary artery disease and hypercholesterolemia and the presence of a pathogenic mutation in the low-density lipoprotein receptor (LDLR) and apolipoprotein B (APOB) genes. Objective: We employed this tool to investigate the prevalence of FH and the associations between FH and coronary artery disease and cholesterol-lowering medication in the Copenhagen General Population Study. Setting: The study was of an unselected, community-based population comprising 69,016 participants. Main Outcome Measures: FH (definite/probable) was defined as a Dutch Lipid Clinic Network score higher than 5. Coronary artery disease was myocardial infarction or angina pectoris. Results: The prevalence of FH was 0.73% (one in 137). Of participants with FH, 20% had an LDLR or APOB mutation. The prevalence of coronary artery disease among FH participants was 33%. Only 48% of subjects with FH admitted to taking cholesterol-lowering medication. The odds ratio for coronary artery disease off cholesterol-lowering medication was 13.2 (10.0–17.4) in definite/probable FH compared with non-FH subjects, after adjusting for age, gender, body mass index, hypertension, metabolic syndrome and diabetes, and smoking. The corresponding adjusted odds ratio for coronary artery disease in FH subjects on cholesterol-lowering medication was 10.3 (7.8–13.8). Conclusion: The prevalence of FH appears to be higher than commonly perceived in a general population of white Danish individuals, with at least half of affected subjects not receiving cholesterol-lowering medication. The very high risk of coronary artery disease irrespective of use of medication reflects the extent of underdiagnosis and undertreatment of FH in the community and primary care.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The frequency of HeFH in the population has earlier been estimated at 1/500; however, recent studies from whole populations suggest that the frequency is higher, in some populations as high as 1/137. 297”
From 2016 ESC/EAS Guidelines for the Management of Dyslipidaemias (2016) · cites this paper as [297]
Citations
Cites
Alberti, K. G. M. M., Eckel, R. H., Grundy, S. M., Zimmet, P. Z., Cleeman, J. I., Donato, K. A., Fruchart, J.-C., James, W. P. T., Loria, C. M., & Smith, S. C. (2009) · Circulation · doi:10.1161/circulationaha.109.192644 · Cited by 14,860
ESC/EAS Guidelines for the management of dyslipidaemias
Reiner, Ž., Catapano, A. L., De Backer, G., Graham, I., Taskinen, M.-R., Wiklund, O., Agewall, S., Alegria, E., Chapman, M. J., Durrington, P., et al. (2011) · European Heart Journal · doi:10.1093/eurheartj/ehr158 · Cited by 3,549
(2003) · Journal of Hypertension · doi:10.1097/00004872-200311000-00002 · Cited by 2,672
Nordestgaard, B. G., Benn, M., Schnohr, P., & Tybjærg-Hansen, A. (2007) · JAMA · doi:10.1001/jama.298.3.299 · Cited by 2,058
Self-citationJones, P. H., Davidson, M. H., Stein, E. A., Bays, H. E., McKenney, J. M., Miller, E., Cain, V. A., & Blasetto, J. W. (2003) · The American Journal of Cardiology · doi:10.1016/s0002-9149(03)00530-7 · Cited by 1,398
Genetically elevated C-reactive protein and ischemic vascular disease
Zacho, J., Tybjærg-Hansen, A., Jensen, J. S., Grande, P., Sillesen, H., & Nordestgaard, B. G. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0707402 · Cited by 839
Self-citationKotseva, K., Wood, D., Backer, G. D., Bacquer, D. D., Pyörälä, K., Keil, U., & EUROASPIRE Study Group (2009) · European Journal of Cardiovascular Prevention & Rehabilitation · doi:10.1097/hjr.0b013e3283294b1d · Cited by 812
Efficacy of statins in familial hypercholesterolaemia: a long term cohort study
Versmissen, J., Oosterveer, D. M., Yazdanpanah, M., Defesche, J. C., Basart, D. C. G., Liem, A. H., Heeringa, J., Witteman, J. C., Lansberg, P. J., Kastelein, J. J. P., et al. (2008) · BMJ · doi:10.1136/bmj.a2423 · Cited by 721
ESC/EAS Guidelines for the management of dyslipidaemias
Catapano, A. L., Reiner, Ž., De Backer, G., Graham, I., Taskinen, M.-R., Wiklund, O., Agewall, S., Alegria, E., Chapman, M. J., Durrington, P., et al. (2011) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2011.06.028 · Cited by 706
Research works printed but not linked: 1
- World Health Organization, 1999, Familial hypercholesterolaemia (FH)
Cited by
Items 501–600 of 632
Deciphering Unexplained Familial Dyslipidemias
Schunkert, H., & Bourier, F. J. (2015) · Circulation Cardiovascular Genetics · doi:10.1161/circgenetics.115.001066 · Cited by 3
The Importance of Genetic Testing for Familial Hypercholesterolemia: A Pediatric Pilot Study
Constantin, A. T., Delia, C., Roșu, L. M., Roșca, I., Streață, I., Riza, A., & Gherghina, I. (2024) · Medicina · doi:10.3390/medicina60101602 · Cited by 6
Long-term impact of telemedicine for lipid control after an acute coronary syndrome
Jiménez-Méndez, C., Vázquez, R., Delgado, W., Bartolome, D., & Silva, E. (2025) · European Journal of Preventive Cardiology · doi:10.1093/eurjpc/zwaf630 · Cited by 2
Bitencourt, I. C., Zimerman, A., & Marston, N. (2026) · Current Atherosclerosis Reports · doi:10.1007/s11883-026-01441-z · Cited by 2
Elmaghraby, K. M., Abdel-Galeel, A., Osman, A. H., Hasan‐Ali, H., & Abdelmegid, M. A.-K. F. (2024) · Scientific Reports · doi:10.1038/s41598-024-77656-4 · Cited by 2
Pathogenicity of the LDLR c. 97C> T (p. Gln33Ter ) Mutation in Familial Hypercholesterolemia
Wang, K., Hu, T., Tai, M., Shen, Y., Lin, S., Guo, Y., & Chen, X. (2024) · Molecular Genetics & Genomic Medicine · doi:10.1002/mgg3.70030 · Cited by 2
Upadhyayula, S. (2024) · Journal of Clinical and Preventive Cardiology · doi:10.4103/jcpc.jcpc_46_24 · Cited by 2
Barbir, M., Breen, J. B., Neves, E., Priestley-Barnham, L., Lazem, F., & Grocott-Mason, R. M. (2019) · Clinical Lipidology and Metabolic Disorders · doi:10.1080/17584299.2019.1587877 · Cited by 3
Evaluation Of Massive Parallel Sequencing As A Diagnostic Tool For Familial Hypercholesterolemia
Radoviča-Spalviņa, I., Bērziņs, R., Latkovskis, G., Frīdmanis, D., Ņikitina-Zaķe, L., Ventiņš, K., Ozola, G., Ērglis, A., & Kloviņš, J. (2014) · Proceedings of the Latvian Academy of Sciences Section B Natural Exact and Applied Sciences · doi:10.2478/prolas-2014-0011 · Cited by 2
Familial hypercholesterolaemia: challenges in primary care
Arnold-Reed, D. E., Pang, J., Vickery, A. W., Bell, D. A., Garton‐Smith, J., Watts, G. F., & Brett, T. (2015) · UWA Profiles and Research Repository (UWA) · Cited by 2
Self-citationFamilial Hypercholesterolemia in Cardiac Rehabilitation: a new field of interest
Ambrosetti, M., Malfatto, G., Cremona, A. M., Arca, M., & Faggiano, P. M. (2015) · Monaldi Archives for Chest Disease · doi:10.4081/monaldi.2014.49 · Cited by 2
Lima-Martínez, M. M., Paoli, M., Vázquez-Cárdenas, A., Magaña‐Torres, M. T., Guevara, O., Muñoz, M. C., Parrilla-Alvarez, A., Márquez, Y., Medeiros, A. M., & Bourbon, M. (2017) · Endocrinología Diabetes y Nutrición (English ed ) · doi:10.1016/j.endien.2017.10.004 · Cited by 3
Update Fettstoffwechselstörungen
Parhofer, K. G. (2013) · Der Internist · doi:10.1007/s00108-013-3335-3 · Cited by 3
ASPECTS OF DETECTING PATIENTS WITH FAMILY HYPERCHOLESTEROLEMIA
Курбанисмаилова, П. М., Попова, А. Б., Юрьевна, Д. Н., & Сергиенко, И. В. (2017) · Journal of clinical practice · doi:10.17816/clinpract8361-69 · Cited by 2
Mehta, O. H., Cameron, J. D., & Mirzaee, S. (2019) · American Journal of Hypertension · doi:10.1093/ajh/hpz037 · Cited by 2
The continuing challenge of familial hypercholesterolaemia
Patel, R. S. (2017) · European Heart Journal - Quality of Care and Clinical Outcomes · doi:10.1093/ehjqcco/qcx029 · Cited by 2
Altschmiedová, T., Vaclová, M., & Vrablík, M. (2018) · Czech and Slovak Ophthalmology · doi:10.31348/2018/1/1-4-2018 · Cited by 1
Hyperlipidemia management in Slovakia: observational study
Fábryová, Ľ., & Nemcová, A. (2019) · Vnitřní lékařství · doi:10.36290/vnl.2019.133 · Cited by 1
Familial hypercholesterolaemia
McErlean, S., Mbakaya, B. C., & Kennedy, C. (2023) · BMJ · doi:10.1136/bmj-2022-073280 · Cited by 1
Familial hypercholesterolemia in Chinese children and adolescents: a multicenter study
Huang, M.-N., Wang, C., Ma, M., Mei-zhu, C., Zhou, Q., Jiang, L., Wang, C., Lü, M., Chen, X., Cheng, Y., et al. (2024) · Lipids in Health and Disease · doi:10.1186/s12944-024-02406-4 · Cited by 1
Shen, T., Luo, R., Jiang, H., Bao, H., Jiang, L., & Cheng, X. (2025) · Lipids in Health and Disease · doi:10.1186/s12944-025-02514-9 · Cited by 3
Langslet, G., Asprusten, E. A., Igland, J., Holven, K. B., Bogsrud, M. P., & Retterstøl, K. (2025) · American Journal of Preventive Cardiology · doi:10.1016/j.ajpc.2025.101043 · Cited by 1
Piechocki, M., Kaźnica-Wiatr, M., & Kabłak-Ziembicka, A. (2025) · Journal of Clinical Medicine · doi:10.3390/jcm14248676 · Cited by 1
Miano, N., Scilletta, S., Marco, M. D., Capuccio, S., Martedì, M., Coppa, M., Tincu, N., Carasi, S., Ippolito, C., Pistritto, C., et al. (2026) · Nutrients · doi:10.3390/nu18060919 · Cited by 1
Yañez, M. J., Campos, F., Valdebenito, P., Cavieres, V. A., Barrera, M., Tapia‐Rojas, C., Burgos, P. V., Monteiro, L. J., Zanlungo, S., Illanes, S. E., et al. (2026) · Journal of Cellular Physiology · doi:10.1002/jcp.70165 · Cited by 2
Childhood screening for familial hypercholesterolaemia: all it takes is a finger prick
Blom, D. J. (2026) · European Heart Journal · doi:10.1093/eurheartj/ehag480 · Cited by 1
Opportunistic Genetic Testing for Familial Hypercholesterolemia in Premature Acute Coronary Syndrome
Vaizman, N., Cermakova, L., Cooper, M., Kramer, A. I., Hui, K., Jackson, L. M., Roston, T. M., Mancini, G. J., Fordyce, C. B., Iatan, I., et al. (2026) · JACC Advances · doi:10.1016/j.jacadv.2026.103053 · Cited by 1
Rodríguez‐Nóvoa, S., Hernández, P. M., Mayoral, I. H., Herranz, A., Roca, N. R., Alvarez, A. C., Onis, N. G., Alcorta, M. D., & Jiménez, C. R. (2026) · Atherosclerosis Plus · doi:10.1016/j.athplu.2026.100607 · Cited by 1
Gao, Y., Yin, H., He, Y., Wu, J., Wang, S., Li, W., Li, X., Wang, O., Zhang, M., & Jiang, L. (2017) · Cited by 1
Genest, J. J., Hegele, R. A., Bergeron, J., Brophy, J. M., Carpentier, A. C., Couture, P., Davignon, J., Dufour, R., Frohlich, J. J., Gaudet, D., et al. (2014) · Cited by 1
Familial hypercholesterolemia: Experience in the Lipid Clinic of Alava
García, L. P. (2018) · Clínica e Investigación en Arteriosclerosis (English Edition) · doi:10.1016/j.artere.2018.04.003 · Cited by 1
Miyazaki, A., Oguri, A., & Shimura, S. (2019) · Japanese Society of Pediatric Cardiology and Cardiac Surgery · doi:10.9794/jspccs.35.112 · Cited by 1
Single Blind Placebo Controlled Study of Herbs
Murad, S., Khalid Niaz, A. P., Mahar, M. R., Awan, P., Azad, A. H., & Sangi, S. (2020) · Scholars Academic Journal of Pharmacy · doi:10.36347/sajp.2020.v09i11.004 · Cited by 1
Wang, Z., Wu, Y., Gao, Y., Qian, J., Liu, L., Guo, Y., Li, J., & Chen, K. (2023) · BMC Cardiovascular Disorders · doi:10.1186/s12872-023-03237-4 · Cited by 1
Matta, A. G., Rabès, J., Taraszkiewicz, D., Carrié, D., Roncalli, J. G., & Ferrières, J. (2023) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2023.1182554 · Cited by 3
Wang, M., Hong, L., Cai, L., Zhang, Z., Jiang, N., Chen, Y., Ying, Q., Kong, L., Wei, Z., Xu, Y., et al. (2024) · Molecular Biology Reports · doi:10.1007/s11033-023-09169-8 · Cited by 1
Opoku-Agyeman, P., Ameyaw, P. A., Bruku, S., Addo, G. O., Tetteh, G., Baafi, E., Asare, S. K., Frimpong, A. F., Adu-Poku, S., Matrevi, S. A., et al. (2025) · Aspects of Molecular Medicine · doi:10.1016/j.amolm.2025.100067 · Cited by 1
Pandey, S., Leider, M., Khan, M., & Grammatopoulos, D. K. (2016) · The Journal of Applied Laboratory Medicine · doi:10.1373/jalm.2016.020610 · Cited by 1
Strategies for identifying familial hypercholesterolaemia in non-specialist clinical settings
Qureshi, N., Weng, S. F., Tranter, J., Silva, M. L. D., Kai, J., & Leonardi‐Bee, J. (2018) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd012985 · Cited by 1
Сергиенко, И. В., & Ansheles, A. A. (2018) · Rational Pharmacotherapy in Cardiology · doi:10.20996/1819-6446-2018-14-1-77-87 · Cited by 2
Celebrating 10 years: The British Heart Foundation's Genetic Information Service
Allen, C., & Davison, J. P. (2019) · British Journal of Cardiac Nursing · doi:10.12968/bjca.2019.0020 · Cited by 1
Registre national de l’hypercholestérolémie familiale : pourquoi et comment ?
Béliard, S. (2020) · Médecine des Maladies Métaboliques · doi:10.1016/j.mmm.2020.06.015 · Cited by 3
Sudden cardiac arrest requiring cardiopulmonary resuscitation during downhill skiing
Masárová, L., Seménka, J., Panovský, R., & Opatřil, L. (2021) · Intervenční a akutní kardiologie · doi:10.36290/kar.2021.006 · Cited by 1
Classifying Familial Hypercholesterolaemia: A Tree-based Machine Learning Approach
Rosli, M. M., Edward, J., Onn, M., Chua, Y.-A., Kasim, N. A. M., & Nawawi, H. M. (2021) · International Journal of Advanced Computer Science and Applications · doi:10.14569/ijacsa.2021.0120908 · Cited by 1
A Case of Heterozygous Familial Hypercholesterolemia: Success of Long-Term Management
Blum, C. B. (2022) · Springer eBooks · doi:10.1007/978-3-030-84367-0_43 · Cited by 1
Kjærgaard, K. A., Harborg, S., Jensen, H. K., & Borgquist, S. (2022) · Lipids in Health and Disease · doi:10.1186/s12944-022-01666-2 · Cited by 1
A familial hypercholesterolemia registry as the main tool for adequate management of the disease
Korneva, V., Kuznetsova, Т. Y., & Julius, U. (2022) · Therapeutic Apheresis and Dialysis · doi:10.1111/1744-9987.13848 · Cited by 1
New Treatments on the Horizon for Familial Hypercholesterolemia
Al‐Rasadi, K., & Al-Waili, K. (2017) · Oman Medical Journal · doi:10.5001/omj.2017.86 · Cited by 2
Polychronopoulos, G., & Τζιόμαλος, Κ. (2019) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2019.1598971 · Cited by 1
To be or not to be resilient in familial hypercholesterolaemia: implications for the management
Mercuro, G., Dessalvi, C. C., & Deidda, M. (2021) · European Journal of Preventive Cardiology · doi:10.1093/eurjpc/zwab197 · Cited by 1
Sarraju, A., & Knowles, J. W. (2019) · Cardiac and vascular biology · doi:10.1007/978-3-030-27371-2_6 · Cited by 1
Khan, A. Z., McCombe, G., McErlean, S., Ledwidge, M. T., Brett, T., Cullen, W., & Gallagher, J. (2023) · medRxiv · doi:10.1101/2023.07.13.23292548 · Cited by 1
Current challenges in the management of patients with familial hypercholesterolemia
Arca, M., Salvia, E., & Pigna, G. (2013) · Clinical Lipidology · doi:10.2217/clp.13.12
Maglio, C. (2014) · Gothenburg University Publications Electronic Archive (Gothenburg University)
Beleslin, B., Deljanin, M., Kanjuh, V., Parapid, B. J., Giga, V. L., Prostran, M. S., Angelkov, L., Balinovac, J., Bikicki, M., Ambrosio, G., et al. (2013)
82 nd Annual Congress of the European Atherosclerosis Society (EAS)
Cuchel, M. (2014)
Corral, P. (2015) · Redalyc (Universidad Autónoma del Estado de México)
The past, present and future of molecular genetic diagnosis in familial hypercholesterolemia
Thomas, E. R. A. (2015) · Clinical Lipidology · doi:10.2217/clp.15.29
Ramakrishnan, V. M. (2015) · ThinkIR: The University of Louisville's Institutional Repository (University of Louisville) · doi:10.18297/etd/2319
Hypercholestérolémie familiale Révision du diagnostic, du dépistage et du traitement
Turgeon, R. D., Barry, A. R., & Pearson, G. J. (2016) · PubMed Central
Active Familial Hypercholesterolemia Case-Finding Through MEDPED General Population Criteria*
Andersen, L. H., Andersen, R. L., Estrella, L., & Testa, H. (2016) · Journal of clinical lipidology · doi:10.1016/j.jacl.2016.03.040
Ambrosetti, M., Malfatto, G., Cremona, A. M., Arca, M., & Faggiano, P. M. (2014)
Integration of Clinical Genetic Testing in Cardiovascular Care
Pariani, M. J., & Knowles, J. W. (2016) · Current Genetic Medicine Reports · doi:10.1007/s40142-016-0094-1 · Cited by 1
Patient experiences of a lipoprotein apheresis service
Datta, D. B. N., & Watkins, S. (2016) · British Journal of Cardiac Nursing · doi:10.12968/bjca.2016.11.10.488
Clinical investigation of subclinical vascular disease in psychosocial stress and dyslipidaemia
Ellins, E. A. (2016) · ORCA Online Research @Cardiff (Cardiff University)
Whitmore, J. (2017) · British Journal of Cardiac Nursing · doi:10.12968/bjca.2017.12.2.58
Mangili, L. C. (2016) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.5.2016.tde-19122016-143332
Hipercolesterolemia familiar heterocigota en manejo con anti–PCSK9
Duque, M., Gaviria, M. C., González, J., & Gallo, J. E. (2017) · Revista Colombiana de Cardiología · doi:10.1016/j.rccar.2017.03.002 · Cited by 3
Quintanilha, B. J. (2018) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/d.6.2018.tde-16042018-175847 · Cited by 1
Chemaly, P., Nallet, O., Delarche, N., Legagneur, C., Boulestreau, R., Reibel, I., Palette, C., Grenier, A., Courtade, H., Beaune, G., et al. (2018) · Annales de Cardiologie et d Angéiologie · doi:10.1016/j.ancard.2018.08.011
Top Tips: Familial hypercholesterolaemia
Wainwright, P., & Waise, A. (2017) · InnovAiT Education and inspiration for general practice · doi:10.1177/1755738017707329
Familial Hypercholesterolaemia Registry in the MENA Region
Kolovou, G. D., & Watts, G. F. (2019) · Current Vascular Pharmacology · doi:10.2174/1570161117999190115151525 · Cited by 1
Self-citationLunegova, O. S., Mirrakhimov, E. M., Hodzhiboboev, E., Bektasheva, E., Neronova, K., Toktomamatov, U. M., Zakirov, U., Asanbaev, A., Arapova, R., Abilova, S., et al. (2019) · Atherosclerosis Supplements · doi:10.1016/j.atherosclerosissup.2019.01.001
A clinical case of hypertrophic cardiomyopathy and family hyperlipidemia
Dankovtseva, E. N., & Zateyshchikov, D. A. (2019) · Journal of clinical practice · doi:10.17816/clinpract10397-101
Hahn, L. A. (2017) · Adelaide Research & Scholarship (AR&S) (University of Adelaide)
MedPed - the reality of familial hypercholesterolemia care at the biggest center
Vaclová, M., Freiberger, T., Schwarzová, L., Tichý, L., Vrablı́k, M., & Češka, R. (2018) · Vnitřní lékařství · doi:10.36290/vnl.2018.006
Ohmura, H. (2021) · Circulation Journal · doi:10.1253/circj.cj-21-0478
de Araújo, A. L. V. (2020) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.5.2020.tde-30062021-101731 · Cited by 1
Abed, A. M., Al-Shuk, M. M., Ahmed, S. T., & Al-Tu’ma, F. J. (2022) · Journal of Contemporary Medical Sciences · doi:10.22317/jcms.v8i1.1164
Zhang, Q., Deng, L., Chen, C., Pan, X., & Jiang, S. (2022) · Endokrynologia Polska · doi:10.5603/ep.a2021.0109
Linden, B. (2013) · British Journal of Cardiac Nursing · doi:10.12968/bjca.2013.8.12.573
Mercado, C. I., & Loustalot, F. V. (2016) · American Public Health Association eBooks · doi:10.2105/9780875532783ch14
Premature coronary atherosclerosis and its relation to familial hypercholesterolemia
Welson, G., & Reda, A. (2022) · Menoufia Medical Journal · doi:10.4103/mmj.mmj_182_21
Flere enn antatt har arvelige dyslipidemier
Johansen, D., Bogsrud, M. P., & Holven, K. B. (2015) · Norsk tidsskrift for ernæring · doi:10.18261/ntfe.13.2.6
[Advances in diagnosis and treatment of familial hypercholesterolemia].
Zheng, H., Jiang, S., & Li, L. (2023) · PubMed Central · doi:10.12122/j.issn.1673-4254.2023.01.22
FAMILIAL HYPERCHOLESTEROLEMIA IN THE FAROE ISLANDS
Borg, S. Á. (2022) · VBN Forskningsportal (Aalborg Universitet) · doi:10.54337/aau518616112
Serra‐Planas, E. (2023) · Lipids in Health and Disease · doi:10.1186/s12944-023-01815-1 · Cited by 1
Gaisenok, O. V. (2023) · Meditsinskiy sovet = Medical Council · doi:10.21518/ms2022-043
Hedegaard, B. S. (2023) · VBN Forskningsportal (Aalborg Universitet) · doi:10.54337/aau539425604
Auf Umwegen in die Lipidambulanz
Stach, K., Schaarschmidt, M., & Adam, R. (2021) · CardioVasc · doi:10.1007/s15027-021-3572-7
Familial hypercholesterolemia and cascade screening for detection of new patients
Rajkovic, N., Popović, L., Lukač, S. S., Rasulić, I., Petakov, A., Krstic, M., & Lalic, K. S. (2023) · Galenika Medical Journal · doi:10.5937/galmed2306021r
Hipercolesterolemia familiar, lipoproteína(a) y aterosclerosis
Rodrigo Alonso, K., & Mata, P. (2023) · Medicina Clínica · doi:10.1016/j.medcli.2023.09.008
Importance of the detection of genetic diseases associated with cardiovascular risk in pediatric age
Resident of Specialization in Pediatrics, U. L. S. C., & Vargas, J. M. S. (2023) · Open Journal of Clinical and Medical Images · doi:10.52768/2833-2725/1132
Familial hypercholesterolemia, lipoprotein(a) and atherosclerosis
Rodrigo Alonso, K., & Mata, P. (2023) · Medicina Clínica (English Edition) · doi:10.1016/j.medcle.2023.09.009
Ginger and Onion: Pakistani Herbs to be used in Treating Hyperlipidemia and Oxidative Stress
Zafar, S., Raza, A. A., Iqbal, M., Tanveer, Z. H., Naqvi, S. Z. H., Shah, A. M., Majeed, F., & Murad, S. (2023) · SAR Journal of Medical Biochemistry · doi:10.36346/sarjmb.2023.v04i04.001
Onion Byproduct Contains Factors with the Ability to Modulate Plasma Lipids and Lipoprotein Levels
Shahab, M. A., Iqbal, M., Hassni, M. A., Muhammad, S. D., Bashir, S., & Baloch, S. M. M. (2023) · SAR Journal of Pathology and Microbiology · doi:10.36346/sarjpm.2023.v04i06.007
Boutgourine, M., Rouam, H., Jamili, M. E., & Hattaoui, M. E. (2024) · Cardiology and Angiology An International Journal · doi:10.9734/ca/2024/v13i1394
Metadata
- Authors
- Benn, M., Watts, G. F., Tybjaerg-Hansen, A., & Nordestgaard, B. G.
- Affiliations
- University of Copenhagen (DK)
- The University of Western Australia (AU)
- The Copenhagen General Population Study (M.B., A.T.-H., B.G.N.), Herlev Hospital, Copenhagen University Hospital, DK-2730 Herlev, Denmark
- Corresponding author
- Nordestgaard, Børge G.
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2012-11-01
- Volume
- 97
- Issue
- 11
- Pages
- 3956-3964
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W1993634977
- Cited by
- 632
- References
- 38
- Citations by year
- 2026: 28 · 2025: 23 · 2024: 28 · 2023: 37 · 2022: 42 · 2021: 36 · 2020: 44 · 2019: 48 · 2018: 61 · 2017: 80 · 2016: 92 · 2015: 53 · 2014: 42 · 2013: 15 · 2012: 1
- FWCI
- 36.15
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
- PubMed (publishedVersion)
- Research at the University of Copenhagen (University of Copenhagen) (publishedVersion)
- UWA Profiles and Research Repository (UWA) (submittedVersion)
- Funders
- Amgen
- Pfizer
- AstraZeneca
- Sanofi
- Sundhed og Sygdom, Det Frie Forskningsråd
- Regeneron Pharmaceuticals
- Gentofte Hospital
- Herlev Hospital
- Medical Research Council
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipoproteins and Cardiovascular Health
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipid metabolism and disorders
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Keywords
- familial hypercholesterolemia, prevalence, coronary artery disease, cholesterol-lowering drugs, LDLR mutations, APOB mutations, Dutch Lipid Clinic Network criteria, underdiagnosis, undertreatment, myocardial infarction, angina pectoris, Copenhagen General Population Study
- MeSH terms
- Aged, Anticholesteremic Agents, Coronary Artery Disease, Denmark, Female, Genotype, Humans, Hyperlipoproteinemia Type II, Lipids, Lipoproteins, Male, Middle Aged, Risk, Prevalence
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.